Direct antiviral agents against hepatitis C virus: Beneficial or harmful?

被引：0
|
作者：
Murcia, Oscar [1 ]
Carnicer, Fernando [1 ]
Gomez-Escolar, Laura [2 ]
Miralles, Cayetano [3 ]
Pilar Grino, Maria [4 ]
Barquero Martin, Claudia [5 ]
Pascual, Sonia [1 ]
机构：
[1] Hosp Gen Univ Alicante, Dept Hepatol, Alicante, Spain
[2] Hosp Marina Baixa, Dept Hepatol, Villajoyosa, Spain
[3] Hosp Vinalopo, Dept Hepatol, Elche, Spain
[4] Hosp San Juan Alicante, Dept Hepatol, Alicante, Spain
[5] Hosp Gen Torrevieja, Dept Hepatol, Alicante, Spain
来源：
JOURNAL OF HEPATOLOGY | 2018年 / 68卷 / 04期
关键词：
INTERFERON-FREE THERAPY; EARLY TUMOR RECURRENCE; HEPATOCELLULAR-CARCINOMA; HCC; RISK;
D O I：
10.1016/j.jhep.2017.10.026
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：844 / 845
页数：2
相关论文
共 50 条
  • [21] The impact of cytokine change after hepatitis C virus clearance by direct antiviral agents on the risk of hepatocellular carcinoma
    Wang, Chia-Chi
    Tseng, Kuo-Chih
    Tzeng, I-Shiang
    Kao, Jia-Horng
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2021, 120 (03) : 965 - 973
  • [22] Metabolism of Direct-acting Antiviral Agents (DAAs) in Hepatitis C Therapy: A Review of the Literature
    Mikolasevic, Ivana
    Kanizaj, Tajana F.
    Bozic, Dorotea
    Puz, Petra
    Stojsavljevic, Sanja S.
    Puljiz, Zeljko
    Radic-Kristo, Delfa
    Lalovac, Milos
    Mijic, Maja
    Delija, Bozena
    Juric, Toni
    Bogadi, Ivan
    Virovic-Jukic, Lucija
    CURRENT DRUG METABOLISM, 2021, 22 (02) : 89 - 98
  • [23] New Direct Acting Antiviral Agents for the Treatment of Hepatitis C: 2016 and Beyond
    Umar, Muhammad
    Akhter, Tayyab Saeed
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2016, 26 (10): : 843 - 850
  • [24] Transformation of hepatitis C antiviral treatment in a national healthcare system following the introduction of direct antiviral agents
    Moon, A. M.
    Green, P. K.
    Berry, K.
    Ioannou, G. N.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (09) : 1201 - 1212
  • [25] Five-Year Prospective Follow-Up of Patients with Hepatitis C Virus Infection Treated with Direct-Acting Antiviral Agents
    Zhang, Yaping
    Xia, Huan
    Fan, Luchang
    Jiang, Lu
    Yang, Bin
    Wang, Fengmei
    INFECTION AND DRUG RESISTANCE, 2025, 18 : 455 - 471
  • [26] Predictive Factors for Hepatocellular Carcinoma Occurrence or Recurrence after Direct-Acting Antiviral Agents in Patients with Chronic Hepatitis C
    Yoshimasu, Yu
    Furuichi, Yoshihiro
    Kasai, Yoshitaka
    Takeuchi, Hirohito
    Sugimoto, Katsutoshi
    Nakamura, Ikuo
    Itoi, Takao
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2019, 28 (01) : 63 - 71
  • [27] Effect of Direct-Acting Antiviral Agents on Gastroesophageal Varices in Patients with Hepatitis C Virus-Related Cirrhosis
    Hisanaga, Hiroshi
    Takedatsu, Hidetoshi
    Emori, Keigo
    Inoue, Hiroto
    Kunitake, Yasuhumi
    Nakane, Tomoyuki
    Fukunaga, Shuhei
    Ide, Tatsuya
    Mitsuyama, Keiichi
    Torimura, Takuji
    MEDICINA-LITHUANIA, 2022, 58 (08):
  • [28] Risk of Hepatocellular Cancer Recurrence in Hepatitis C Virus+ Patients Treated with Direct-Acting Antiviral Agents
    Winnie Y. Zou
    Kati Choi
    Jennifer R. Kramer
    Xian Yu
    Yumei Cao
    Hashem B. El-Serag
    Fasiha Kanwal
    Digestive Diseases and Sciences, 2019, 64 : 3328 - 3336
  • [29] Direct-acting antiviral drugs and hepatitis C virus: A therapeutic revolution?
    Braillon, Alain
    CANCER, 2015, 121 (23) : 4268 - 4269
  • [30] De-novo versus recurrent hepatocellular carcinoma following direct-acting antiviral therapy for hepatitis C virus
    Abdelaziz, Ashraf O.
    Nabil, Mohamed M.
    Abdelmaksoud, Ahmed H.
    Shousha, Hend I.
    Cordie, Ahmed A.
    Hassan, Eman M.
    Omran, Dalia A.
    Leithy, Rania
    Elbaz, Tamer M.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 30 (01) : 39 - 43
12345